Literature DB >> 3882273

Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.

T G Rosano.   

Abstract

Cyclosporine concentrations in whole blood and plasma were determined in 25 samples from renal-transplant patients. The portion of cyclosporine carried in plasma varied widely, from 9 to 58%. Radioimmunoassay and liquid chromatography both revealed a statistically significant inverse correlation between hematocrit and the plasma fraction of cyclosporine in the circulating blood. Regression analysis indicates that a 10% increase in hematocrit would decrease the portion of cyclosporine in plasma by 12 to 14%. Studies with cyclosporine-supplemented samples further demonstrated an effect of hematocrit on the drug concentration in plasma without a corresponding effect on the concentration in whole blood. The distribution of cyclosporine between plasma and erythrocytes was unaffected by plasma cholesterol and triglycerides for these transplant patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882273

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  The influence of haematocrit on blood cyclosporin measurements in vivo.

Authors:  A Johnston; J T Marsden; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

2.  Blood protein binding of cyclosporine in transplant patients.

Authors:  I Zaghloul; R J Ptachcinski; G J Burckart; D Van Thiel; T E Starzel; R Venkataramanan
Journal:  J Clin Pharmacol       Date:  1987-03       Impact factor: 3.126

3.  Assessment of variables contributing to cyclosporine distribution in blood.

Authors:  S O Broin; E Clarke; S McCann
Journal:  Ir J Med Sci       Date:  1990 Sep-Dec       Impact factor: 1.568

Review 4.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

Review 6.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

Review 7.  Cyclosporin clinical pharmacokinetics.

Authors:  A Fahr
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

Review 9.  Therapeutic drug monitoring of cyclosporin. Practical applications and limitations.

Authors:  V Rodighiero
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.